cbdMD (YCBD) Cash from Financing Activities (2016 - 2025)

cbdMD has reported Cash from Financing Activities for 10 years, with the latest figure at $2.1 million in Q4 2025.

• Quarterly Cash from Financing Activities changed N/A year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 173.01% YoY) and the FY2025 annual result came in at $1.4 million, up 11.39% from the prior year.
• Cash from Financing Activities grew to $2.1 million in Q4 2025 per YCBD's latest filing, from $1.4 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $13.8 million in Q3 2021 and troughed at -$1.1 million in Q4 2022.
• A 5-year average of $752267.8 and a median of -$619751.0 in 2021 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2021 and 2025: Cash from Financing Activities plunged 142.35% in 2021, then soared 144523500.0% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$1.0 million in 2021, then retreated by 10.92% to -$1.1 million in 2022, then jumped by 99.78% to -$2501.0 in 2023, then soared by 100.04% to $1.0 in 2024, then soared by 210395600.0% to $2.1 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $2.1 million, $1.4 million, and $1.0 for Q4 2025, Q3 2025, and Q3 2024 respectively.